会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Cardiac stimulation device including sleep apnea prevention and treatment
    • 心脏刺激装置包括睡眠呼吸暂停预防和治疗
    • US07212862B2
    • 2007-05-01
    • US10247137
    • 2002-09-18
    • Euljoon ParkSteve KohGene A. Bornzin
    • Euljoon ParkSteve KohGene A. Bornzin
    • A61N1/365
    • A61N1/36585A61N1/3601A61N1/36542A61N1/36557
    • An implantable cardiac stimulation device comprises a physiologic sensor and one or more pulse generators. The physiologic sensor is capable of sensing a physiologic parameter. The pulse generators can generate cardiac pacing pulses with a timing based on the physiologic parameter. The timed cardiac pacing pulses can prevent a sleep apnea condition. In one example, a cardiac stimulation device has a physiologic sensor and can be configured to pace a patient's heart according to a rest mode of operation. The cardiac stimulation device uses measurements from the physiologic sensor to prevent and treat sleep apnea using a revised rest mode of operation. The revised rest mode operates under a presumption that sleep apnea is primary to a reduced heart rate, rather than secondary, so that pacing at a rate higher than the natural cardiac rate during sleep will prevent sleep apnea.
    • 植入式心脏刺激装置包括生理传感器和一个或多个脉冲发生器。 生理传感器能感测生理参数。 脉冲发生器可以产生基于生理参数的定时的心脏起搏脉冲。 定时的心脏起搏脉冲可以防止睡眠呼吸暂停状态。 在一个示例中,心脏刺激装置具有生理传感器,并且可以被配置为根据休息的操作模式来对患者的心脏进行加速。 心脏刺激装置使用来自生理传感器的测量来使用修改的休息模式来预防和治疗睡眠呼吸暂停。 修改后的休息模式的作用是假设睡眠呼吸暂停是降低心率而不是继发性睡眠呼吸暂停的原因,因此在睡眠期间以高于自然心率的速率起搏将防止睡眠呼吸暂停。
    • 6. 发明授权
    • System and method for monitoring thoracic fluid levels based on impedance using an implantable medical device
    • 使用可植入医疗装置基于阻抗监测胸水液位的系统和方法
    • US08032212B2
    • 2011-10-04
    • US12210848
    • 2008-09-15
    • Gene A. BornzinSteve KohEuljoon Park
    • Gene A. BornzinSteve KohEuljoon Park
    • A61B5/02A61B5/08A61B5/05A61N1/00
    • A61N1/36521A61B5/0537A61B5/4869
    • Techniques are provided for monitoring thoracic fluid levels based on thoracic impedance (ZT) and cardiogenic impedance (ZC). In one example, the implantable device tracks the maximum time rate of change in cardiogenic impedance (i.e. max(dZC/dt)) to detect trends toward hypervolemic or hypovolemic states within the patient based on changes in heart contractility. The detection of these trends in combination with trends in thoracic impedance allows for a determination of whether the thoracic cavity of the patient is generally “too wet” or “too dry,” and thus allows for the titration of diuretics to avoid such extremes. In particular, a decrease in thoracic impedance (ZT) in combination with a decrease in max (dZC/dt) is indicative of the thorax being “too wet” (i.e. a fluid overload). Conversely, an increase in thoracic impedance (ZT) in combination with a decrease in max (dZC/dt) is indicative of the thorax being “too dry” (i.e. a fluid underload).
    • 提供了基于胸部阻抗(ZT)和心源阻抗(ZC)监测胸水水平的技术。 在一个示例中,可植入装置跟踪心源性阻抗的最大时间变化率(即max(dZC / dt)),以基于心脏收缩力的变化来检测患者内的高血容量或低血容量状态的趋势。 这些趋势的检测结合胸部阻抗趋势可以确定患者的胸腔通常是否“太湿”或“太干”,从而允许滴定利尿剂以避免这种极端。 特别地,胸部阻抗(ZT)的降低与最大值(dZC / dt)的降低相结合表明胸部“太湿”(即流体过载)。 相反,胸部阻抗(ZT)的增加与最大(dZC / dt)的降低相结合,表明胸部“太干”(即,流体欠载)。
    • 7. 发明申请
    • SYSTEM AND METHOD FOR MONITORING THORACIC FLUID LEVELS BASED ON IMPEDANCE USING AN IMPLANTABLE MEDICAL DEVICE
    • 基于使用可植入医疗器械的阻抗监测胸腔液体水平的系统和方法
    • US20100069778A1
    • 2010-03-18
    • US12210848
    • 2008-09-15
    • Gene A. BornzinSteve KohEuljoon Park
    • Gene A. BornzinSteve KohEuljoon Park
    • A61B5/053
    • A61N1/36521A61B5/0537A61B5/4869
    • Techniques are provided for monitoring thoracic fluid levels based on thoracic impedance (ZT) and cardiogenic impedance (ZC). In one example, the implantable device tracks the maximum time rate of change in cardiogenic impedance (i.e. max(dZC/dt)) to detect trends toward hypervolemic or hypovolemic states within the patient based on changes in heart contractility. The detection of these trends in combination with trends in thoracic impedance allows for a determination of whether the thoracic cavity of the patient is generally “too wet” or “too dry,” and thus allows for the titration of diuretics to avoid such extremes. In particular, a decrease in thoracic impedance (ZT) in combination with a decrease in max (dZC/dt) is indicative of the thorax being “too wet” (i.e. a fluid overload). Conversely, an increase in thoracic impedance (ZT) in combination with a decrease in max (dZC/dt) is indicative of the thorax being “too dry” (i.e. a fluid underload).
    • 提供了基于胸部阻抗(ZT)和心源阻抗(ZC)监测胸水水平的技术。 在一个示例中,可植入装置跟踪心源性阻抗的最大时间变化率(即max(dZC / dt)),以基于心脏收缩力的变化来检测患者内的高血容量或低血容量状态的趋势。 这些趋势的检测结合胸部阻抗的趋势可以确定患者的胸腔通常是否“太湿”或“太干”,从而允许滴定利尿剂以避免这种极端。 特别地,胸部阻抗(ZT)的降低与最大值(dZC / dt)的降低相结合表明胸部“太湿”(即流体过载)。 相反,胸部阻抗(ZT)的增加与最大(dZC / dt)的降低相结合,表明胸部“太干”(即,流体欠载)。
    • 8. 发明授权
    • System and method for determining patient posture based on 3-D trajectory using an implantable medical device
    • 使用可植入医疗装置的基于3D轨迹确定患者姿势的系统和方法
    • US07149579B1
    • 2006-12-12
    • US10329233
    • 2002-12-23
    • Steve KohMark W. KrollEuljoon ParkGene A. Bornzin
    • Steve KohMark W. KrollEuljoon ParkGene A. Bornzin
    • A61N1/00
    • A61N1/3925A61N1/36535A61N1/36542
    • Time-varying spatial signals are detected by accelerometers mounted within the patient. The signals, representative of the actual 3-D trajectory of the patient, are compared with information representative of expected trajectories retrieved from memory to identify a current patient posture, which may be either a dynamic posture such as walking or running or a change in posture such as rising from a seated position to a standing position. In this manner, a change in posture of the patient is identified based upon a full 3-D trajectory, rather than merely the orientation of the patient at the beginning and the end of the change in posture. In an example described herein, the implantable device stores information representative of expected 3-D trajectories in the form of pre-calculated comparison matrices derived from orthonormal kernels employing Laguerre functions or Lagrange functions. A technique is also described for use by an external programmer for pre-calculating comparison matrices so as to reduce the processing burden within the implanted device during posture detection.
    • 时变空间信号由安装在患者体内的加速度计检测。 将代表患者的实际3-D轨迹的信号与表示从存储器检索到的预期轨迹的信息进行比较,以识别当前患者姿势,其可以是动态姿势,例如步行或跑步或姿势变化 例如从就座位置升高到站立位置。 以这种方式,基于完整的3-D轨迹来识别患者姿势的变化,而不仅仅是患者在姿势改变的开始和结束时的取向。 在本文所描述的示例中,可植入装置以使用拉格朗日函数或拉格朗日函数的从正常内核导出的预先计算的比较矩阵的形式存储表示预期3-D轨迹的信息。 还描述了一种用于外部编程器用于预计算比较矩阵的技术,以便在姿势检测期间减少植入装置内的处理负担。